strain P0), after 10 passages across a triclosan gradient (P10; SCV) and after a further 10 140 passages in the absence of triclosan (X10).
141
Selection of isolates with reduced triclosan susceptibility. Reproducible 142 concentration gradients of triclosan were created on TSA agar by depositing stock solutions 143 of triclosan (100 μg/ml-10 mg/ml) with a Wasp II spiral plater (Don Whitley, Shipley, 144 United Kingdom) (6). Plates were dried for 1 h at room temperature prior to radial deposition 145 of an overnight suspension of S. aureus and incubated for 4 days aerobically at 37°C. Growth 146 observed at the highest triclosan concentration was removed and used to inoculate further 147 gradient plates. This process was repeated for 10 passages. A further 10 passages were 148 performed on triclosan-free TSA. Isolates (the parent P0 strain), those passaged 10 times on 149 triclosan (strain P10), and those passaged a further 10 times on triclosan-free TSA (strain 150 X10) were archived at −80°C for subsequent analyses.
151
Minimum inhibitory concentrations (MICs) and minimum bactericidal 152 concentrations (MBCs). MIC values were determined using the micro dilution method as 153 described previously (40) . Briefly, overnight bacterial cultures were adjusted to an OD 600 of 154 0.8 and diluted 1:100 in TSB to produce a bacterial inoculum for susceptibility testing. 155 Inocula were incubated with doubling dilutions of the relevant microbicide at 37ºC for 24 h. 156 The MIC was defined as the lowest concentration for which bacterial growth did not occur. however X10 strains only showed a significantly different susceptibility than P0 to 250 trimethoprim-sulfamethoxazole and cephalothin. In non-SCV forming strains, NCTC 6571 251 exhibited a significant increase in cephalothin susceptibility after repeated triclosan exposure, 252 whilst NCTC 13142 showed a reduction in trimethoprim-sulfamethoxazole susceptibility, 253 neither of which fully reverted to pre-exposure levels in the absence of triclosan, (P<0.05). and recovered X10 strain were visualised using TEM (Figure 2 fully reverted to pre-exposure levels in the absence of any microbicide (X10). In the current investigation, the repeated exposure of S. aureus to triclosan selected for 294 substantially reduced triclosan susceptibility in 6/6 test strains whilst only 4/6 formed the 295 SCV phenotype. In SCVs, antibiotic susceptibility significantly increased in 3/5 strains for 296 tetracycline, 2/5 for kanamycin, 5/5 for gentamicin, 3/5 for trimethoprim-sulfamethoxazole, 297 1/5 for ampicillin, 2/5 for ciprofloxacin and 4/5 for cephalothin. The only decrease in 298 antibiotic susceptibility observed in a SCV was in S. aureus Newman for trimethoprim-299 sulfamethoxazole, which reverted in the absence of triclosan. In the two non-SCV forming 300 strains, only NCTC 6571 showed a significant increase in antibiotic susceptibility after 301 triclosan exposure (to cephalothin), whilst non-SCV forming strain NCTC 13142 showed a 302 significant decrease in trimethoprim-sulfamethoxazole susceptibility. S. aureus strain ATCC 303 6538 SCV R1 exhibited the largest increase in both triclosan and antibiotic susceptibility 304 when compared to the P0 and was therefore further evaluated for alterations in protein 305 expression, competitive fitness, cationic microbicide susceptibility and cellular morphology. (1) 28 (1) 15 (4) 15 (2) 16 (1) 23 (1) 22 (2) 23 (2) 29 (2) 25 (2) 25 (1) 12 (2) 13 (1) 13 20 (4) 23 (1) 23 (2) 28 (1) 28 (1) 28 (1) Antibiotic disc diffusion zones of inhibition (mm) of S. aureus before triclosan exposure (P0), after sub-lethal triclosan exposure (P10) and after recovery in a triclosan-free environment (X). or MBC compared to that of the parent strain (P0). aureus ATCC 6538. Proteins of interest were excised and identified using esi MS-MS. Indicated proteins were identified as FabI (1) IsaA (2) and Def (3). B) Identities and functions of proteins selected from 2D gels of S. aureus ATCC 6538 that were upregulated in triclosan induced SCVs. 574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594 
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